FATE THERAPEUTICS INC Stock-Based Compensation
FATE THERAPEUTICS INC (FATE) reported Stock-Based Compensation of $3.52 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-13
- FATE THERAPEUTICS INC share-based payment arrangement, expense for the quarter ending 2026-06-30 was $3.52M, a 50.82% decline year-over-year.
- FATE THERAPEUTICS INC share-based payment arrangement, expense for the quarter ending 2026-03-31 was $3.93M, a 46.77% decline year-over-year.
- FATE THERAPEUTICS INC share-based payment arrangement, expense for the quarter ending 2025-12-31 was $5.53M, a 39.39% decline year-over-year.
- FATE THERAPEUTICS INC share-based payment arrangement, expense for the quarter ending 2025-09-30 was $4.86M, a 58.68% decline year-over-year.
- FATE THERAPEUTICS INC share-based payment arrangement, expense for fiscal 2025 was $24.92M, a 39.94% decline from fiscal 2024.
- FATE THERAPEUTICS INC share-based payment arrangement, expense for fiscal 2024 was $41.50M, a 4.52% decline from fiscal 2023.
- FATE THERAPEUTICS INC share-based payment arrangement, expense for fiscal 2023 was $43.46M, a 44.80% decline from fiscal 2022.
- FATE THERAPEUTICS INC share-based payment arrangement, expense for fiscal 2022 was $78.73M, a 44.83% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 80 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.52M 10-Q · filed 2026-08-13 | $7.45M 10-Q · filed 2026-08-13 | $12.97M derived: sum of 3 quarters · filed 2026-08-13 | $17.84M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $3.93M 10-Q · filed 2026-05-13 | $9.46M derived: sum of 2 quarters · filed 2026-05-13 | $14.32M derived: sum of 3 quarters · filed 2026-05-13 | $21.47M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.39M derived: sum of 2 quarters · filed 2026-02-26 | $17.54M derived: sum of 3 quarters · filed 2026-08-13 | $24.92M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $4.86M 10-Q · filed 2025-11-13 | $12.02M derived: sum of 2 quarters · filed 2026-08-13 | $19.40M 10-Q · filed 2025-11-13 | $28.52M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $7.15M 10-Q · filed 2026-08-13 | $14.54M 10-Q · filed 2026-08-13 | $23.66M derived: sum of 3 quarters · filed 2026-08-13 | $35.42M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $7.38M 10-Q · filed 2026-05-13 | $16.50M derived: sum of 2 quarters · filed 2026-05-13 | $28.27M derived: sum of 3 quarters · filed 2026-05-13 | $37.90M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $9.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $20.89M derived: sum of 2 quarters · filed 2026-02-26 | $30.52M derived: sum of 3 quarters · filed 2026-02-26 | $41.50M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $11.77M 10-Q · filed 2025-11-13 | $21.39M derived: sum of 2 quarters · filed 2025-11-13 | $32.38M 10-Q · filed 2025-11-13 | $41.85M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $9.63M 10-Q · filed 2025-08-12 | $20.61M 10-Q · filed 2025-08-12 | $30.09M derived: sum of 3 quarters · filed 2025-08-12 | $40.19M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $10.98M 10-Q · filed 2025-05-13 | $20.46M derived: sum of 2 quarters · filed 2025-05-13 | $30.56M derived: sum of 3 quarters · filed 2025-05-13 | $43.46M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $9.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $19.58M derived: sum of 2 quarters · filed 2025-03-05 | $32.48M derived: sum of 3 quarters · filed 2025-03-05 | $43.46M 10-K · filed 2025-03-05 | |
| 2023-09-30 | $10.10M 10-Q · filed 2024-11-12 | $23.00M derived: sum of 2 quarters · filed 2024-11-12 | $33.98M 10-Q · filed 2024-11-12 | $53.38M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $12.90M 10-Q · filed 2024-08-13 | $23.88M 10-Q · filed 2024-08-13 | $43.27M derived: sum of 3 quarters · filed 2024-08-13 | $62.74M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $10.98M 10-Q · filed 2024-05-09 | $30.38M derived: sum of 2 quarters · filed 2024-05-09 | $49.84M derived: sum of 3 quarters · filed 2024-05-09 | $70.39M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $19.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $38.86M derived: sum of 2 quarters · filed 2024-02-26 | $59.40M derived: sum of 3 quarters · filed 2024-02-26 | $78.73M 10-K · filed 2024-02-26 | |
| 2022-09-30 | $19.47M 10-Q · filed 2023-11-08 | $40.01M derived: sum of 2 quarters · filed 2023-11-08 | $59.34M 10-Q · filed 2023-11-08 | $73.94M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $20.54M 10-Q · filed 2023-08-08 | $39.87M 10-Q · filed 2023-08-08 | $54.47M derived: sum of 3 quarters · filed 2023-08-08 | $68.01M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $19.33M 10-Q · filed 2023-05-03 | $33.92M derived: sum of 2 quarters · filed 2023-05-03 | $47.47M derived: sum of 3 quarters · filed 2023-05-03 | $60.72M derived: sum of 4 quarters · filed 2023-05-03 | |
| 2021-12-31 | $14.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $28.13M derived: sum of 2 quarters · filed 2023-02-28 | $41.39M derived: sum of 3 quarters · filed 2023-02-28 | $54.36M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $13.54M 10-Q · filed 2022-11-03 | $26.79M derived: sum of 2 quarters · filed 2022-11-03 | $39.77M 10-Q · filed 2022-11-03 | $48.53M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $13.25M 10-Q · filed 2022-08-03 | $26.23M 10-Q · filed 2022-08-03 | $34.99M derived: sum of 3 quarters · filed 2023-02-28 | $42.83M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $12.98M 10-Q · filed 2022-05-04 | $21.74M derived: sum of 2 quarters · filed 2023-02-28 | $29.58M derived: sum of 3 quarters · filed 2023-02-28 | $36.82M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $8.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $16.60M derived: sum of 2 quarters · filed 2023-02-28 | $23.84M derived: sum of 3 quarters · filed 2023-02-28 | $30.75M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $7.84M 10-Q · filed 2021-11-04 | $15.08M derived: sum of 2 quarters · filed 2021-11-04 | $21.99M 10-Q · filed 2021-11-04 | $26.57M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $7.24M 10-Q · filed 2021-08-04 | $14.15M 10-Q · filed 2021-08-04 | $18.73M derived: sum of 3 quarters · filed 2022-02-28 | $23.30M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | $6.91M 10-Q · filed 2021-05-05 | $11.50M derived: sum of 2 quarters · filed 2022-02-28 | $16.07M derived: sum of 3 quarters · filed 2022-02-28 | $20.45M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $9.16M derived: sum of 2 quarters · filed 2022-02-28 | $13.54M derived: sum of 3 quarters · filed 2022-02-28 | $17.41M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $4.57M 10-Q · filed 2020-11-05 | $8.96M derived: sum of 2 quarters · filed 2020-11-05 | $12.83M 10-Q · filed 2020-11-05 | $14.61M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $4.39M 10-Q · filed 2020-08-05 | $8.25M 10-Q · filed 2020-08-05 | $10.04M derived: sum of 3 quarters · filed 2021-02-24 | $11.68M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $3.87M 10-Q · filed 2020-05-11 | $5.65M derived: sum of 2 quarters · filed 2021-02-24 | $7.29M derived: sum of 3 quarters · filed 2021-02-24 | $8.78M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $3.43M derived: sum of 2 quarters · filed 2021-02-24 | $4.91M derived: sum of 3 quarters · filed 2021-02-24 | $6.29M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $1.64M 10-Q · filed 2019-11-05 | $3.13M derived: sum of 2 quarters · filed 2019-11-05 | $4.51M 10-Q · filed 2019-11-05 | $5.40M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $1.49M 10-Q · filed 2019-08-06 | $2.87M 10-Q · filed 2019-08-06 | $3.76M derived: sum of 3 quarters · filed 2020-03-02 | $4.63M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $1.38M 10-Q · filed 2019-05-07 | $2.28M derived: sum of 2 quarters · filed 2020-03-02 | $3.15M derived: sum of 3 quarters · filed 2020-03-02 | $4.12M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $895.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.77M derived: sum of 2 quarters · filed 2020-03-02 | $2.74M derived: sum of 3 quarters · filed 2020-03-02 | $3.61M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $871.00K 10-Q · filed 2018-11-01 | $1.84M derived: sum of 2 quarters · filed 2018-11-01 | $2.71M 10-Q · filed 2018-11-01 | $3.53M derived: sum of 4 quarters · filed 2019-03-05 | |
| 2017-06-30 | $973.00K 10-Q · filed 2018-08-06 | $1.84M 10-Q · filed 2018-08-06 | $2.66M derived: sum of 3 quarters · filed 2019-03-05 | $3.44M derived: sum of 4 quarters · filed 2019-03-05 | |
| 2017-03-31 | $867.00K 10-Q · filed 2018-05-10 | $1.69M derived: sum of 2 quarters · filed 2019-03-05 | $2.47M derived: sum of 3 quarters · filed 2019-03-05 | $3.25M derived: sum of 4 quarters · filed 2019-03-05 | |
| 2016-12-31 | $819.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $1.60M derived: sum of 2 quarters · filed 2019-03-05 | $2.39M derived: sum of 3 quarters · filed 2019-03-05 | $3.18M 10-K · filed 2019-03-05 | |
| 2016-09-30 | $783.00K 10-Q · filed 2017-11-01 | $1.57M derived: sum of 2 quarters · filed 2017-11-01 | $2.37M 10-Q · filed 2017-11-01 | $2.85M derived: sum of 4 quarters · filed 2018-03-05 | |
| 2016-06-30 | $786.00K 10-Q · filed 2017-08-14 | $1.58M 10-Q · filed 2017-08-14 | $2.06M derived: sum of 3 quarters · filed 2018-03-05 | $2.64M derived: sum of 4 quarters · filed 2018-03-05 | |
| 2016-03-31 | $797.00K 10-Q · filed 2017-05-15 | $1.28M derived: sum of 2 quarters · filed 2018-03-05 | $1.85M derived: sum of 3 quarters · filed 2018-03-05 | $2.59M derived: sum of 4 quarters · filed 2018-03-05 | |
| 2015-12-31 | $480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $1.05M derived: sum of 2 quarters · filed 2018-03-05 | $1.79M derived: sum of 3 quarters · filed 2018-03-05 | $2.40M 10-K · filed 2018-03-05 | |
| 2015-09-30 | $574.00K 10-Q · filed 2016-11-07 | $1.31M derived: sum of 2 quarters · filed 2016-11-07 | $1.92M 10-Q · filed 2016-11-07 | $2.53M derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-06-30 | $738.00K 10-Q · filed 2016-08-08 | $1.35M 10-Q · filed 2016-08-08 | $1.96M derived: sum of 3 quarters · filed 2017-03-16 | $2.48M derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-03-31 | $608.00K 10-Q · filed 2016-05-09 | $1.22M derived: sum of 2 quarters · filed 2017-03-16 | $1.75M derived: sum of 3 quarters · filed 2017-03-16 | $2.17M derived: sum of 4 quarters · filed 2017-03-16 | |
| 2014-12-31 | $612.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.14M derived: sum of 2 quarters · filed 2017-03-16 | $1.56M derived: sum of 3 quarters · filed 2017-03-16 | $2.43M 10-K · filed 2017-03-16 | |
| 2014-09-30 | $527.00K 10-Q · filed 2015-11-03 | $951.00K derived: sum of 2 quarters · filed 2015-11-03 | $1.82M 10-Q · filed 2015-11-03 | $2.21M derived: sum of 4 quarters · filed 2016-03-03 | |
| 2014-06-30 | $424.00K 10-Q · filed 2015-08-05 | $1.29M 10-Q · filed 2015-08-05 | $1.68M derived: sum of 3 quarters · filed 2016-03-03 | $2.66M derived: sum of 4 quarters · filed 2016-03-03 | |
| 2014-03-31 | $871.00K 10-Q · filed 2015-05-07 | $1.26M derived: sum of 2 quarters · filed 2016-03-03 | $2.24M derived: sum of 3 quarters · filed 2016-03-03 | $2.35M derived: sum of 4 quarters · filed 2016-03-03 | |
| 2013-12-31 | $385.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $1.37M derived: sum of 2 quarters · filed 2016-03-03 | $1.48M derived: sum of 3 quarters · filed 2016-03-03 | $1.55M 10-K · filed 2016-03-03 | $2.32M 10-K · filed 2014-03-17 |
| 2013-09-30 | $982.00K 10-Q · filed 2014-11-12 | $1.09M derived: sum of 2 quarters · filed 2014-11-12 | $1.17M 10-Q · filed 2014-11-12 | ||
| 2013-06-30 | $112.00K 10-Q · filed 2014-08-12 | $187.00K 10-Q · filed 2014-08-12 | |||
| 2013-03-31 | $75.00K 10-Q · filed 2014-05-13 | ||||
| 2012-12-31 | $155.00K 10-K · filed 2015-03-12 | ||||
| 2011-12-31 | $172.00K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |